As a result, the resultant p53 R273H mutant protein leads to acquired multidrug resistance in colon cancer cells, suggesting that p53 mRNA is a direct target of METTL3 (Fig. 2d). The gene discussed is TP53; the disease is malignant colon neoplasm.